Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0010073,
umls-concept:C0012984,
umls-concept:C0030956,
umls-concept:C0042397,
umls-concept:C0079284,
umls-concept:C0205042,
umls-concept:C0205227,
umls-concept:C0205314,
umls-concept:C0232338,
umls-concept:C0679622,
umls-concept:C1280500,
umls-concept:C1314939,
umls-concept:C1522564,
umls-concept:C1998811
|
pubmed:issue |
4
|
pubmed:dateCreated |
1989-11-2
|
pubmed:abstractText |
We examined the effect of endothelin on the canine coronary artery (N = 20). The left circumflex coronary artery was cannulated and perfused with arterial blood at constant pressure. Coronary blood flow was monitored by an electromagnetic flowmeter. Intracoronary endothelin provoked a vasoconstriction that was dose-dependent. At a dose of 500 pmol, coronary blood flow was reduced remarkably (91.0 +/- 5.4%, n = 4), and endothelin subsequently produced a fall in systemic blood pressure and ST elevation in the electrocardiogram. At a dose of 100 pmol (n = 9), coronary flow decreased from 16.4 +/- 1.5 ml/min to 12.5 +/- 1.5 ml/min (p less than 0.001) and coronary vascular resistance increased from 6.3 +/- 0.8 mm Hg/ml/min to 9.9 +/- 1.9 mm Hg/ml/min (p less than 0.005). A cumulative dose-response curve to endothelin was obtained and the curves were shifted to the right after both verapamil and nifedipine administration. Therefore endothelin has a potent vasoconstrictor action that is attenuated by the calcium-channel blocker.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0002-8703
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
118
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
674-8
|
pubmed:dateRevised |
2006-2-27
|
pubmed:meshHeading |
pubmed-meshheading:2679015-Animals,
pubmed-meshheading:2679015-Blood Pressure,
pubmed-meshheading:2679015-Coronary Circulation,
pubmed-meshheading:2679015-Coronary Vasospasm,
pubmed-meshheading:2679015-Coronary Vessels,
pubmed-meshheading:2679015-Dogs,
pubmed-meshheading:2679015-Dose-Response Relationship, Drug,
pubmed-meshheading:2679015-Electrocardiography,
pubmed-meshheading:2679015-Endothelins,
pubmed-meshheading:2679015-Endothelium, Vascular,
pubmed-meshheading:2679015-Nifedipine,
pubmed-meshheading:2679015-Peptides,
pubmed-meshheading:2679015-Vasoconstriction,
pubmed-meshheading:2679015-Verapamil
|
pubmed:year |
1989
|
pubmed:articleTitle |
Vasoconstrictor effect of endothelin on the canine coronary artery: is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm?
|
pubmed:affiliation |
First Department of Internal Medicine, Niigata University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article
|